These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26918044)

  • 21. Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma.
    Yeh CF; Chan TC; Ke HL; Chen TJ; Wu LC; Lee HY; Wei YC; Wu WJ; Li CF; Li WM
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma.
    Liang PI; Li WM; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Wei YC; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Lin CM; Li CF
    BMC Cancer; 2012 Dec; 12():611. PubMed ID: 23259573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma.
    Chen TJ; Chan TC; Li WS; Li CF; Ke HL; Wei YC; Wu WJ; Li WM
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34204134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder.
    Chang IW; Lin VC; Wu WJ; Liang PI; Li WM; Yeh BW; He HL; Liao AC; Chan TC; Li CF
    J Cancer; 2016; 7(11):1396-405. PubMed ID: 27471555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis.
    Li WM; Chan TC; Wei YC; Li CF; Ke HL; Wu WJ; Hsu CC; Wang SC; Yeh CF
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):217. PubMed ID: 37796703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma.
    Kuo YH; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Lu JC; Li CF
    Onco Targets Ther; 2022; 15():727-740. PubMed ID: 35795328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis.
    Lai HY; Chiu CC; Kuo YH; Tsai HH; Wu LC; Tseng WH; Liu CL; Hsing CH; Huang SK; Li CF
    Front Oncol; 2022; 12():834249. PubMed ID: 35372028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas.
    Chan TC; Li CF; Ke HL; Wei YC; Shiue YL; Li CC; Yeh HC; Lee HY; Huang SK; Wu WJ; Li WM
    Urol Oncol; 2019 Apr; 37(4):293.e11-293.e24. PubMed ID: 30595463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma.
    Li WM; Ke HL; Kuo YH; Lai HY; Chan TC; Hsing CH; Hsieh KL; Li WS; Chen TJ; Wei YC; Wu WJ; Huang SK; Li CF
    Oncology; 2022; 100(9):485-497. PubMed ID: 35817020
    [No Abstract]   [Full Text] [Related]  

  • 30. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma.
    Chuang HW; Hsia KT; Liao JB; Yeh CC; Kuo WT; Yang YF
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma.
    Kuo YH; Chan TC; Lai HY; Chen TJ; Wu LC; Hsing CH; Li CF
    Front Oncol; 2021; 11():749142. PubMed ID: 34589439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer.
    De Faveri LE; Hurst CD; Platt FM; Taylor CF; Roulson JA; Sanchez-Carbayo M; Knowles MA; Chapman EJ
    Br J Cancer; 2013 Apr; 108(6):1368-77. PubMed ID: 23549060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis.
    Chien TM; Chan TC; Huang SK; Yeh BW; Li WM; Huang CN; Li CC; Wu WJ; Li CF
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32182788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High G protein subunit beta 4 protein level is correlated to poor prognosis of urothelial carcinoma.
    Chen TJ; Dehghanian SZ; Chan TC; He HL; Li WS; Abdollahi S; Chen NY; Li CF; Shiue YL
    Med Mol Morphol; 2021 Dec; 54(4):356-367. PubMed ID: 34398348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Expression of 17β-hydroxysteroid Dehydrogenase Type 2 is Associated with a Better Prognosis in Urothelial Carcinoma of the Urinary Tract.
    Wang CT; Li CF; Wu WJ; Huang CN; Li CC; Li WM; Chan TC; Liang PI; Hsing CH; Liao KM
    J Cancer; 2016; 7(15):2221-2230. PubMed ID: 27994658
    [No Abstract]   [Full Text] [Related]  

  • 36. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma.
    Li CF; Shen KH; Huang LC; Huang HY; Wang YH; Wu TF
    Pathology; 2010 Jan; 42(1):43-9. PubMed ID: 20025479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of lactate dehydrogenase B subunit expression is correlated with tumour progression and independently predicts inferior disease-specific survival in urinary bladder urothelial carcinoma.
    Liao AC; Li CF; Shen KH; Chien LH; Huang HY; Wu TF
    Pathology; 2011 Dec; 43(7):707-12. PubMed ID: 22027740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
    Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
    J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
    Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
    J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.
    Wang YH; Wu WJ; Wang WJ; Huang HY; Li WM; Yeh BW; Wu TF; Shiue YL; Sheu JJ; Wang JM; Li CF
    Oncotarget; 2015 Oct; 6(31):31069-84. PubMed ID: 26307680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.